Clinical News

FDA Approves First Gene TherapyWhy the agency says the approval of Novartis’ new therapy is historic.
FDA Cracks Down on Regenerative and Stem Cell Therapies
FDA Cracks Down on Regenerative and Stem Cell TherapiesNew therapies hold great promise—and great danger.
Ninjacof Recall, Tied to Previous PharmaTech RecallsThe recall is just the latest in a bacterial contamination scare.
Online Pharmacies: A Safety Concern?
Online Pharmacies: A Safety Concern?Why the NABP says Canada isn't a safe alternative.
New Bill Could Force E-prescribing
New Bill Could Force E-prescribingLegislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.
Mylan Finalizes $465 Million EpiPen Settlement
Mylan Finalizes $465 Million EpiPen SettlementThe settlement is the end of a long legal battle.
Express Scripts Limits Opioid Prescriptions
Express Scripts Limits Opioid PrescriptionsThe PBM giant is cutting down on the number of opioids new patients can buy.
Inconsistent Labeling of Sulfites Could Cause HarmA tricky labeling system could be affecting your patients.
Biosimilars Market Taking Off in the United StatesAfter many years of speculation, a number of biosimilar drugs are hitting the U.S. market.
Amneal Recalls 13 Lots of Lorazepam Oral
Amneal Recalls 13 Lots of Lorazepam OralThe provided droppers may have been mislabeled.